HELXvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with HELX, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
HELX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/29/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HELX ETF 2 | +3.65%– | +18.42%– | +26.78%– | +34.48%– | +81.47%– | -13.69%– |
| Flows | HELX ETF 2 | +$2M– | +$2M– | +$8M– | +$8M– | +$17M– | +$8M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HELX ETF 2 | +27.48%– | +24.10%– | +21.93%– | +23.67%– |
| Max drawdown | HELX ETF 2 | -8.93%– | -17.89%– | -29.16%– | -55.27%– |
| Max drawdown duration | HELX ETF 2 | 22d– | 206d– | 458d– | 1822d– |
Trading data
HELX | ETF 2 | |
Last sale 10/30/2026 at 1:30 PM | $45.25 | – |
| Previous close 10/29/2026 | $46.01 | – |
| Consolidated volume 10/29/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
HELX | ETF 2 | |
|---|---|---|
| Last price | $45.25 | – |
| 1D performance | -1.65% | – |
| AuM | $36.80 M | – |
| E/R | 0.5% | – |
Characteristics
HELX | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Franklin Templeton | – |
| Benchmark | - | – |
| N° of holdings | 66 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 25, 2020 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
HELX
USA
90.13%
Other
9.87%
ETF 2
Sectors
HELX
Healthcare
97.01%
Other
2.99%
ETF 2
Advertisement
Diversification
HELX
Total weight of top 15 holdings out of 15
61.42%
ETF 2
–
Top 15 holdings
Data as of September 30, 2026
HELX
Natera, Inc.
10.25%
Guardant Health, Inc.
9.72%
Krystal Biotech, Inc.
5.32%
Twist Bioscience Corp.
5.01%
Adaptive Biotechnologies Corp.
4.95%
Ligand Pharmaceuticals, Inc.
4.33%
BridgeBio Pharma, Inc.
2.79%
Travere Therapeutics, Inc.
2.72%
Medpace Holdings, Inc.
2.64%
Vertex Pharmaceuticals, Inc.
2.62%
Corteva, Inc.
2.33%
Eli Lilly & Co.
2.25%
Tempus AI, Inc.
2.25%
United Therapeutics Corp.
2.20%
Repligen Corp.
2.04%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
